ARTICLE | Company News
Medarex, m-phasys deal
November 19, 2001 8:00 AM UTC
The companies will develop and market human antibodies against G protein-coupled receptors (GPCRs). The companies will use m-phasys' M-FOLD refolding technology to produce functional GPCRs, and MEDX w...